Bortezomib 2mg Injection Bortenat

Bortezomib 2mg injection, sold under the brand name Bortenat, is a proteasome inhibitor used primarily in the treatment of multiple myeloma and mantle cell lymphoma. It works by targeting and inhibiting the proteasome, a protein complex responsible for breaking down unnecessary or damaged proteins. This mechanism helps slow or stop the growth of cancer cells.

• Treatment of multiple myeloma, a type of cancer that affects plasma cells.
• Treatment of mantle cell lymphoma, a type of non-Hodgkin lymphoma.

Bortezomib 2mg Injection is given as an intravenous (IV) or subcutaneous (SC) injection by a healthcare professional. The dosage and treatment schedule depends on the patient’s condition, body weight, and response to therapy.

1. HIGHLY EFFECTIVE TREATMENT: Known for its efficacy in managing Multiple Myeloma and other malignant diseases.
2. HIGH-QUALITY STANDARDS: Manufactured in WHO-GMP-approved facilities to ensure global quality compliance.
3. SAFE & RELIABLE: Tested for safety and efficacy for cancer treatment.

• It should only be given under the supervision of a qualified oncologist.
• Not recommended for use during pregnancy or breastfeeding, unless prescribed.
• Patients should be monitored for side effects such as neuropathy, gastrointestinal problems, or low blood cell counts.

Check this Anti Cancer product Bortezomib 2mg Injection Bortetor or you may explore more Anti Cancer products by clicking here

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.